Tyra Biosciences, Inc. Quarterly Debt-to-equity in % from Q2 2022 to Q4 2024

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: Tyra Biosciences, Inc. quarterly Debt-to-equity history and growth rate from Q2 2022 to Q4 2024.
Tyra Biosciences, Inc. Debt-to-equity for the quarter ending December 31, 2024 was 4.76 %, a 21.7% decline year-over-year.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date
Q4 2024	4.76	-1.32	-21.7%	Dec 31, 2024
Q3 2024	5.34	+0.97	+22.2%	Sep 30, 2024
Q2 2024	5.79	+2.41	+71.2%	Jun 30, 2024
Q1 2024	6.08	+3.12	+106%	Mar 31, 2024
Q4 2023	6.07	+3.09	+104%	Dec 31, 2023
Q3 2023	4.37	+1.8	+70.1%	Sep 30, 2023
Q2 2023	3.38	+1.08	+46.8%	Jun 30, 2023
Q1 2023	2.95			Mar 31, 2023
Q4 2022	2.98			Dec 31, 2022
Q3 2022	2.57			Sep 30, 2022
Q2 2022	2.31			Jun 30, 2022

* An asterisk sign (*) next to the value indicates that the value is likely invalid.